- 
        
                             AbbVie Inc. (ABBV $217.94) AbbVie Inc. (ABBV $217.94)
- 
        
                             Danaher Corporation (DHR $215.45) Danaher Corporation (DHR $215.45)
- 
        
                             Eli Lilly and Company (LLY $858.30) Eli Lilly and Company (LLY $858.30)
- 
        
                             Thermo Fisher Scientific Inc (TMO $564.06) Thermo Fisher Scientific Inc (TMO $564.06)
- 
        
                             Lantheus Holdings Inc. (LNTH $56.28) Lantheus Holdings Inc. (LNTH $56.28)
            Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?
        
     
                             
                             
                    